Christopher J. Lafargue
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Glutathione Transferases and Polymorphisms, Protein Degradation and Inhibitors, Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments
Most-Cited Works
- → SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas(2009)945 cited
- → Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma(2010)468 cited
- → Exploring and comparing adverse events between PARP inhibitors(2019)462 cited
- → Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease(2009)404 cited
- → TMPRSS2–ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african‐american and japanese patients(2010)273 cited
- → EML4-ALK Fusion Lung Cancer: A Rare Acquired Event(2008)247 cited
- → Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort(2010)183 cited
- → N-myc Downstream Regulated Gene 1 (NDRG1) Is Fused to ERG in Prostate Cancer(2009)132 cited
- → Distinct genomic aberrations associated with ERG rearranged prostate cancer(2009)89 cited
- → Amplification of chromosomal segment 4q12 in non-small cell lung cancer(2009)83 cited